In our recent paper, we reported an aminoglycoside-sensing RNA in the leader RNA of the aminoglycoside acetyl transferase (AAC) and aminoglycoside adenyl transferase (AAD), enzymes that confer resistance to aminoglycoside antibiotics through modification of the drugs. Our study explains a well-known phenomenon: the induction of expression levels of the AAC/AAD proteins on addition of aminoglycosides (Williams and Northrop, 1976) . In this paper, we presented data that showed: (1) aminoglycoside-specific induction of reporter genes mediated by the leader RNA of the AAC in Pseudomonas fluorescens; (2) aminoglycoside binding to the leader RNA by surface plasmon resonance spectroscopy (SPR); (3) that binding induces a structural transition in the leader RNA that can be detected by changes in gel electrophoretic mobility and chemical probing; (4) the identification of a specific aminoglycoside-RNA crosslink; (5) confirmation, via mutational analysis, of the main features of the RNA secondary structure and the importance of structural elements within it for drug binding.
We show these aspects of our study to be internally consistent and complementary. The six 4,6 deoxystreptamine aminoglycosides that induce the reporter gene bind well to the leader RNA by SPR and cause a structural transition in the RNA, as measured by chemical probing. The three control molecules that do not induce reporter gene expression bind weakly to the leader RNA by SPR and do not cause a structural transition in the RNA by chemical probing. We have reporter assays, SPR, and chemical probing data that are all in clear and good agreement. In our view, these data are consistent with a riboswitch model of regulation for aac/aad genes.
In the accompanying Correspondence in this issue of Cell, Roth and Breaker suggest that the binding that we measure reflects spurious electrostatic drug-RNA interactions. However, the correlation between the in vitro binding that we measure by SPR and the specificity of the reporter gene induction argues against this. Accordingly, the aminoglycosides that bind weakly do not induce the reporter gene, whereas aminoglycosides that bind with high affinity induce leader-RNA-mediated reporter gene expression, suggesting that the binding that we measure is biologically relevant. Moreover, in reporter assays in which the leader RNA of aac/aad is replaced by a different leader RNA (cat-86), we no longer observe induction of the reporter gene, suggesting that the interaction between inducing aminoglycosides and the leader RNA of aac/aad is very specific. Additional roles are emerging for aminoglycosides as cellular modulators and subinhibitory doses induce biofilm formation (Hoffman et al., 2005) and the bacterial SOS response (Baharoglu and Mazel, 2011) .
Roth and Breaker assert that riboswitches typically influence reporter gene expression over a range of 10-to 1000-fold, but this is only correct for some riboswitches. A number of riboswitches display lower levels of reporter gene expression; for example, the adenine binding add riboswitch (Lemay et al., 2011) shows 3-fold induction and the guanine riboswitch, 6.7-fold repression (Mandal et al., 2003) . Riboflavin represses the FMN riboswitch 5-fold (Lee et al., 2009) , and the S-adenosyl methioninebinding S MK riboswitch is repressed 2-to 3-fold (Smith et al., 2010) . Thus, the levels of reporter gene expression measured in solution in our reporter assay are close to previously characterized translational riboswitches and are consistent with the translational riboswitch that we propose. However, we initially measured reporter gene expression by agar diffusion assays-a more sensitive assay system in which induction of gene expression can be directly visualized on agar plates (Bailey et al., 2008) . We consistently observed clear induction of reporter gene expression as blue rings on plates by the inducing aminoglycosides and no induction by the control drugs. This method provides an independent confirmation of our solution-based reporter gene expression measurements. Roth and Breaker propose that aminoglycosides work by targeting the ribosome to change global protein production and cause small changes in reporter gene expression; this is not consistent with the known mechanism of ribosomal inhibition. The aminoglycosides are inhibitors of translation, and they do not increase global protein production. In both reporter assays, we see induction of the reporter gene by the inducing aminoglycosides; i.e., we see increased protein production. Furthermore, the three control drugs do not cause induction of the reporter gene through the same leader RNA, suggesting that the induction that we observed was genuine. Nor do we observe induction of reporter genes for the control cat-86 leader RNA, suggesting that the induction that we measure is specific for the aac/aad leader RNA. We also observe aminoglycoside-dependent induction of reporter gene expression in cells in which ribosomes were methylated (to block aminoglycoside binding); therefore, the induction that we see is independent of aminoglycoside binding to ribosomes and cannot be explained by antibioticribosome binding, as stated by Roth and Breaker.
Roth and Breaker propose that the aminoglycoside-dependent induction of gene expression that we measure is comparable with an investigation on the translational function of attI1 site-specific integron sequences (Hanau-Berç ot et al., 2002; Jacquier et al., 2009 ). Although nucleotides 1-39 of the leader RNA of aac/aad from Pseudomonas fluorescens are the same as in Citrobacter freundii, the remaining sequence differs. The minimal functional aminoglycosidesensing RNA that we identified is 75 nucleotides (nt). There is, however, a very important difference between the two studies: we measure induction of reporter gene expression in the presence of added aminoglycoside, whereas Hanau-Berç ot and colleagues measured steady-state translation in the absence of any drug. This is a significant difference because our main purpose was to understand how aminoglycosides induce acc/ aad gene expression. These studies are therefore not directly comparable.
To investigate the role of the leader peptide in the induction of gene expression, we made three mutations (M23-25) in which the leader RNA sequence was altered but the amino acid sequence of the leader peptide was retained. M23-25 greatly reduced the induction of the reporter gene. Roth and Breaker propose that, in M23-25, a point mutation (C11A) outside of the peptide-coding sequence introduces the sequence AAAGA, which could act as a decoy SD sequence to disrupt gene expression. This C11A mutation was introduced to destabilize a potential competing RNA structure. To test the function of this proposed decoy SD sequence, we repaired the mutation (C11A) to the wild-type RNA and made new mutant constructs M23*-5*. We found that M23*-5*, which do not contain the proposed decoy SD sequence, also greatly reduce the induction of the reporter gene and have the same phenotype as M23-25 ( Figure S1 available online). There is, therefore, no evidence for a decoy SD sequence, as proposed by Roth and Breaker, and our original conclusion on the role of leader peptide is confirmed. Mutant M4 that lacks the C11A mutation also supports this conclusion. The induction of the reporter gene by aminoglycosides does not depend on leader peptide expression.
The aminoglycoside-sensing RNA that we have characterized contains an RNA fragment that overlaps a DNA sequence containing a strong promoter, the conserved 5 0 attI1 site of a class 1 integron, and extends beyond it to the neighboring gene. Although we noted the association with the integron cassette system in the Results and Discussion sections, we did not discuss this in depth because we regarded the relationship between a sitespecific DNA recombination system and our regulatory RNA as beyond the scope of the paper.
Roth and Breaker then argue that, because the attI1 site functions as a specific recombination site in DNA, it is inconsistent with a regulatory role for the corresponding RNA. We emphasize that the leader RNA we studied is indeed the 5 0 UTR of the aac/aad gene of Pseudomonas fluorescens, although the corresponding DNA sequence contains the attI1 site (Hanau-Berç ot et al., 2002) . We defined the minimal functional unit of the aminoglycoside-sensing RNA as 75 nt in length, which contains other important sequences (SD2 and anti-SD) in addition to the attI1 site. The RNA sequence that corresponds to the attI1 site alone may not function as a riboswitch on its own. Furthermore, blast analysis indicates that sequences related to the aac/ aad leader RNA are predominately associated with AAC or AAD resistance proteins in class 1 integrons. Integrons are known to be inseparable from antibiotic resistance. The association of an antibiotic resistance gene with a site-specific recombination site would confer a selective advantage to the integron in an antibiotic-rich environment. A concurrent inducible riboswitch that responds to a commonly used antibiotic would therefore give an additional selective advantage to the integron cassette.
Roth and Breaker note that other aminoglycoside resistance genes (Table  S1A) are not associated with attI1 sites, but this is because resistance to aminoglycosides can be conferred by diverse biochemical mechanisms (inactivation, efflux, or rRNA methylation), and there is no reason to expect a common riboswitch mechanism for their control.
Resistance to antibiotics has emerged over the last 60 or so years in response to a highly selective antibiotic-rich environment. It has become a major clinical threat, and an understanding of the mechanism of resistance is critical. In our view, our data demonstrate an aminoglycoside-sensing RNA that regulates an aminoglycoside antibiotic-resistant gene. We thank Drs. Roth and Breaker for discussion and the further opportunity to clarify our data. 
